Related Experiment Video
Updated: Nov 1, 2025

A Simple Cell-based Immunofluorescence Assay to Detect Autoantibody Against the N-Methyl-D-Aspartate NMDA Receptor in Blood
Published on: January 9, 2018
Anti-NMDA receptor autoimmune encephalitis: a case report
1Specialist Physician, General Medicine Department, Middlemore Hospital, Auckland.
A previously healthy woman developed neurological symptoms including insomnia and memory loss after starting fluoxetine and temazepam for anxiety. These symptoms progressed to confusion and paranoia, suggesting a potential adverse drug reaction.
Area of Science:
- Neuroscience
- Psychiatry
- Clinical Pharmacology
Background:
- A 42-year-old female presented with insomnia, concentration difficulties, and short-term memory impairment.
- The patient denied any history of illicit drug use.
Observation:
- Treatment with fluoxetine and temazepam was initiated for presumed anxiety.
- Following medication initiation, the patient experienced acute confusion and paranoid delusions.
- The patient developed a delusion that her partner intended to harm her.
Findings:
- The clinical presentation suggests a potential adverse reaction to fluoxetine and/or temazepam.
- The neurological and psychiatric symptoms evolved after the introduction of these medications.
- Differential diagnosis should consider medication side effects in patients with new-onset cognitive and psychotic symptoms.
Implications:
- This case highlights the importance of considering medication side effects in the differential diagnosis of new-onset neurological and psychiatric symptoms.
- Further investigation is warranted to determine the specific agent responsible and the underlying mechanism.
- Clinicians should maintain a high index of suspicion for drug-induced psychosis and cognitive impairment.
More Related Videos
10:19High-throughput Flow Cytometry Cell-based Assay to Detect Antibodies to N-Methyl-D-aspartate Receptor or Dopamine-2 Receptor in Human Serum
Published on: November 23, 2013
08:20Hippocampal Neuronal Cultures to Detect and Study New Pathogenic Antibodies Involved in Autoimmune Encephalitis
Published on: June 2, 2022